Vitagerpavak the international language is called herpes vaccine.
Thus, Vitagerpavak - a tool used in the treatment of herpes simplex virus human type I and II.
Pharmacological action Vitagerpavaka
The drug belongs to the MIP, or medical immunobiological preparations. This group includes means for developing a stable body resistance to certain viruses. Unlike other agents of this group, the vaccine is characterized by a complex structure, the production technology and numerous embodiments immune response by the patient's body. Therefore, control over the use of such vaccines in practice, to be special.
Action Vitagerpaka according to the instructions to the drug, designed to stimulate the cellular mechanisms of the human body to the herpes simplex virus, belonging to the types I and II, according to the medical classification of the disease.
Vitagerpaka vaccine is inactivated antigen related to the herpes simplex virus. This antigen is grown with the use of laboratory techniques, reproductive way on the basis of special cell cultures (Vero B).
Auxiliaries, members of the drug are:
- Gentamicin Sulfate - 40 mcg / ml;
- Sucrose (stabilizer) - 75 mg / ml;
- Zhelatoza - 10 mg / ml;
- Formaldehyde (virus inactivator) - 200 mcg / ml.
Vitagerpavak a dry substance for the preparation of the solution. The vaccine is an amorphous mass, the color ranges from yellow to pink color, hygroscopic. Vitagerpavak according to the instructions produced in bottles of 0, 3 ml. Usually, one dose vaccination at 0, 2 ml. The vials are packed into boxes, each of which contains five vials.
Each box Vitagerpavaka instructions for use of the drug.
The drug Vitagerpavak for the prevention of herpes infection and recurrence of the disease.
Vaccination is used for activation of cellular immunity, immune and its specific desensitization (purification and recovery) of an organism.
Thus, according to the instructions Vitagerpavaku and medical reviews, vaccination is recommended in the following categories of patients:
- Chronically ill herpes infection, with clinical manifestations and relapses (exacerbation), if the disease is repeated more than three times a year;
- Elderly (over 60 - 65 years);
- HIV patients in stages I and II, to the development of active symptoms of AIDS.
Vaccination according to the instructions Vitagerpavaku, carried out exclusively in hospitals, under the supervision of a physician. The vaccine is applied in remission after complete disappearance of clinical manifestations of herpes infection, but no sooner than 5 days. The vaccine is administered intradermally, using a syringe with a single dose. The injection is carried out in the forearm (at its inner surface). A full course of vaccination (for herpes infections of the skin and mucous membranes) of the reviews Vitagerpavake practitioners is 5 injections are carried out at intervals of a week or 10 days.
In case of complications of herpes infection, as well as reviews of evidence Vitagerpavake physicians, the interval between injections is 15 days. Six months later, carried out a second full course of immunization of 5 injections, in order to consolidate the therapeutic effect.
Adverse reactions from the use of Vitagerpavaka
Local reaction to the introduction of the drug according to the reviews Vitagerpavak patients, causes skin flushing (redness). Typically, the diameter of the area of skin with redness up to 2 cm. Reviews Vitagerpavake contain information that congestion occurs, usually within the first days after vaccination. Along with redness from reviews Vitagerpavake known that the body's response also appears in the form of short-term, poor burning. From reviews Vitagerpavake scientists and physicians learned that such reactions are perfectly normal and natural.
The general reaction of the body, according to the instructions Vitagerpavaku, also causes a slight increase in body temperature and a small weakness. These reactions are themselves and do not require treatment.
The emergence of a much more severe local or general reaction, exacerbation of the main process, demands an end to further vaccination.
There are some reviews of Vitagerpavake, which marked significant implications of ignoring pronounced adverse reactions to the drug. That is why, in the event of such reactions, it is necessary to address urgently to the hospital. The doctor will examine all cases strongly expressed local and general reactions and enters the data into the appropriate medical document. Application Vitagerpaka according to the instructions thereto may be continued only after the complete disappearance of all forms of local and general reactions to the introduction of the drug.
Contraindications to the use of the vaccine according to the instructions Vitagerpavak serve the following diseases and other conditions of patients:
- Idiosyncratic hypersensitivity to the drug or any antibiotic gentamicin aminoglikozidovoy group;
- The active phase of herpes infection. Vaccination is permitted no earlier than 5 days since the disappearance of all forms of herpes infection, and in the case of ophthalmic (mucous membrane of the eye) - no earlier than one month;
- Acute diseases (infectious and noninfectious);
- Chronic diseases in the acute stage and decompensation;
- Any malignant neoplasms;
- The presence of the active symptoms of AIDS.